Why is Ondine Biomedical, Inc. ?
1
Flat results in Dec 24
- PRE-TAX PROFIT(Q) At GBP -6.48 MM has Fallen at -61.44%
- NET PROFIT(Q) At GBP -6.48 MM has Fallen at -61.44%
- INTEREST(HY) At GBP 0.01 MM has Grown at 31.94%
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 45.16%, its profits have risen by 373%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Ondine Biomedical, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Ondine Biomedical, Inc.
-100.0%
0.99
55.58%
FTSE 100
16.5%
1.23
12.99%
Quality key factors
Factor
Value
Sales Growth (5y)
-8.47%
EBIT Growth (5y)
24.65%
EBIT to Interest (avg)
-20.37
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.42
Sales to Capital Employed (avg)
17.39
Tax Ratio
39.42%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
345.04%
ROE (avg)
123.78%
Valuation Key Factors 
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
16.79
EV to EBIT
18.99
EV to EBITDA
12.16
EV to Capital Employed
-36.69
EV to Sales
1.15
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
86.80%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Ondine Biomedical, Inc.
Inventory Turnover Ratio
Highest at 1.08% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -267.12% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Ondine Biomedical, Inc.
Pre-Tax Profit
At GBP -6.48 MM has Fallen at -61.44%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (GBP MM)
Net Profit
At GBP -6.48 MM has Fallen at -61.44%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (GBP MM)
Interest
At GBP 0.01 MM has Grown at 31.94%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (GBP MM)






